Acquired hypocalciuric hypercalcemia (Q65581): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:18, 14 August 2026
Patients with acquired hypocalciuric hypercalcaemia present the same clinical features to those with familial hypocalciuric hypercalcemia. While familial hypocalciuric hypercalcemia is caused by mutations in several genes including CASR which encodes calcium-sensin receptor, acquired hypocalciuric hypercalcaemia is caused by the production of inhibitory autoantibodies to calcium-sensing receptor.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1325071304 |
||
| English | Acquired hypocalciuric hypercalcemia |
Patients with acquired hypocalciuric hypercalcaemia present the same clinical features to those with familial hypocalciuric hypercalcemia. While familial hypocalciuric hypercalcemia is caused by mutations in several genes including CASR which encodes calcium-sensin receptor, acquired hypocalciuric hypercalcaemia is caused by the production of inhibitory autoantibodies to calcium-sensing receptor. |
Statements
CID11:ID_1325071304
0 references
dki-india-ID_1325071304
0 references
Concluído
0 references
13 August 2026
0 references
